T-CELLS MODIFIED TO OVEREXPRESS PHF19

Technology
E-107-2017
Patent ID
E-107-2017-0-US-04
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
11883431
Publication Number
US-2020-0289562-A1
Application Number
16/619,570
IC
NCI
Date Filed
Date Issued
Patent PDF
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11883431
Related Technologies
TAB-4030     Overexpression of Phf19 on T Cells Enhances Therapeutic Effects of T Cell-Based Therapies (such as Chimeric Antigen Receptor [CAR] Therapies)